HHS SEC ROBERT F KENNEDY JR: American patients pay more so others can pay less — that stops now
President Donald Trump’s bold executive order on drug pricing isn’t just policy—it’s a revolution in healthcare affordability. The plan is simple yet transformative: ensure Americans pay no more for medications than citizens of other wealthy nations. Consider this stark reality: a GLP-1 drug costing $88 in London commands $1,000 in the United States. Even after…

